Search

everythinglearnresearchcommunity

for

Search:↓

Thai people's hair density decreases with age and varies by scalp area, but hair thickness stays the same regardless of age or scalp area.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

PRP treatment helps hair growth and density with 70.7% success, but more research needed.

Sensitive skin often causes discomfort, affects many people, especially women and older adults, and should be managed with careful product selection.

A young man was initially misdiagnosed with a scalp condition but was found to have a fungal infection, which improved with antifungal treatment.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Combining electrodynamic microneedle with 5% minoxidil improves hair growth and reduces hair loss in Chinese men.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Minoxidil helps hair growth and boosts self-esteem in balding men.

The laser scanner device was more effective at increasing hair density than the laser hat in treating androgenic alopecia.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.